nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Myocardial ischaemia—Floxuridine—stomach cancer	0.0208	0.0426	CcSEcCtD
Fenoldopam—Injection site reaction—Mitomycin—stomach cancer	0.0131	0.0267	CcSEcCtD
Fenoldopam—Angina pectoris—Floxuridine—stomach cancer	0.0102	0.0209	CcSEcCtD
Fenoldopam—Haemoglobin—Floxuridine—stomach cancer	0.00845	0.0173	CcSEcCtD
Fenoldopam—Haemorrhage—Floxuridine—stomach cancer	0.0084	0.0172	CcSEcCtD
Fenoldopam—Myocardial ischaemia—Irinotecan—stomach cancer	0.0071	0.0145	CcSEcCtD
Fenoldopam—Muscle spasms—Floxuridine—stomach cancer	0.00703	0.0144	CcSEcCtD
Fenoldopam—Myocardial ischaemia—Fluorouracil—stomach cancer	0.0068	0.0139	CcSEcCtD
Fenoldopam—Leukocytosis—Fluorouracil—stomach cancer	0.00581	0.0119	CcSEcCtD
Fenoldopam—Lactic dehydrogenase activity increased—Epirubicin—stomach cancer	0.0052	0.0106	CcSEcCtD
Fenoldopam—Myocardial ischaemia—Docetaxel—stomach cancer	0.0049	0.01	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Floxuridine—stomach cancer	0.00488	0.00998	CcSEcCtD
Fenoldopam—Lactic dehydrogenase activity increased—Doxorubicin—stomach cancer	0.00481	0.00983	CcSEcCtD
Fenoldopam—Myocardial ischaemia—Capecitabine—stomach cancer	0.00475	0.00971	CcSEcCtD
Fenoldopam—Abdominal pain—Floxuridine—stomach cancer	0.00472	0.00965	CcSEcCtD
Fenoldopam—Body temperature increased—Floxuridine—stomach cancer	0.00472	0.00965	CcSEcCtD
Fenoldopam—Blood lactate dehydrogenase increased—Epirubicin—stomach cancer	0.00458	0.00935	CcSEcCtD
Fenoldopam—Extrasystoles—Capecitabine—stomach cancer	0.00454	0.00927	CcSEcCtD
Fenoldopam—Transaminases increased—Epirubicin—stomach cancer	0.00437	0.00894	CcSEcCtD
Fenoldopam—Oliguria—Docetaxel—stomach cancer	0.00428	0.00875	CcSEcCtD
Fenoldopam—Blood lactate dehydrogenase increased—Doxorubicin—stomach cancer	0.00423	0.00866	CcSEcCtD
Fenoldopam—Dyspnoea—Mitomycin—stomach cancer	0.00418	0.00854	CcSEcCtD
Fenoldopam—Diarrhoea—Floxuridine—stomach cancer	0.00409	0.00835	CcSEcCtD
Fenoldopam—Cardiac failure—Fluorouracil—stomach cancer	0.00406	0.00831	CcSEcCtD
Fenoldopam—Transaminases increased—Doxorubicin—stomach cancer	0.00404	0.00827	CcSEcCtD
Fenoldopam—Injection site reaction—Docetaxel—stomach cancer	0.00392	0.00801	CcSEcCtD
Fenoldopam—Blood creatinine increased—Irinotecan—stomach cancer	0.00388	0.00793	CcSEcCtD
Fenoldopam—Vomiting—Floxuridine—stomach cancer	0.0038	0.00776	CcSEcCtD
Fenoldopam—Injection site reaction—Capecitabine—stomach cancer	0.00379	0.00776	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Irinotecan—stomach cancer	0.00378	0.00773	CcSEcCtD
Fenoldopam—Hypokalaemia—Irinotecan—stomach cancer	0.00377	0.0077	CcSEcCtD
Fenoldopam—Headache—Floxuridine—stomach cancer	0.00374	0.00765	CcSEcCtD
Fenoldopam—Body temperature increased—Mitomycin—stomach cancer	0.0037	0.00757	CcSEcCtD
Fenoldopam—Nausea—Floxuridine—stomach cancer	0.00355	0.00725	CcSEcCtD
Fenoldopam—Angina pectoris—Irinotecan—stomach cancer	0.00349	0.00713	CcSEcCtD
Fenoldopam—Angina pectoris—Fluorouracil—stomach cancer	0.00334	0.00682	CcSEcCtD
Fenoldopam—Diarrhoea—Mitomycin—stomach cancer	0.00321	0.00655	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Irinotecan—stomach cancer	0.00315	0.00643	CcSEcCtD
Fenoldopam—Myocardial infarction—Irinotecan—stomach cancer	0.00313	0.00639	CcSEcCtD
Fenoldopam—Dizziness—Mitomycin—stomach cancer	0.0031	0.00633	CcSEcCtD
Fenoldopam—Oliguria—Methotrexate—stomach cancer	0.00308	0.0063	CcSEcCtD
Fenoldopam—Sweating—Irinotecan—stomach cancer	0.00306	0.00625	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Fluorouracil—stomach cancer	0.00301	0.00616	CcSEcCtD
Fenoldopam—Myocardial infarction—Fluorouracil—stomach cancer	0.003	0.00612	CcSEcCtD
Fenoldopam—Vomiting—Mitomycin—stomach cancer	0.00298	0.00609	CcSEcCtD
Fenoldopam—Urinary tract infection—Fluorouracil—stomach cancer	0.00297	0.00607	CcSEcCtD
Fenoldopam—Headache—Mitomycin—stomach cancer	0.00294	0.006	CcSEcCtD
Fenoldopam—Cardiac failure—Docetaxel—stomach cancer	0.00293	0.006	CcSEcCtD
Fenoldopam—Bradycardia—Irinotecan—stomach cancer	0.00292	0.00596	CcSEcCtD
Fenoldopam—Oliguria—Epirubicin—stomach cancer	0.00289	0.0059	CcSEcCtD
Fenoldopam—Haemoglobin—Irinotecan—stomach cancer	0.00288	0.00588	CcSEcCtD
Fenoldopam—Haemorrhage—Irinotecan—stomach cancer	0.00286	0.00586	CcSEcCtD
Fenoldopam—Cardiac failure—Capecitabine—stomach cancer	0.00284	0.0058	CcSEcCtD
Fenoldopam—Creatinine increased—Epirubicin—stomach cancer	0.00279	0.00571	CcSEcCtD
Fenoldopam—Nausea—Mitomycin—stomach cancer	0.00278	0.00569	CcSEcCtD
Fenoldopam—Haemoglobin—Fluorouracil—stomach cancer	0.00276	0.00564	CcSEcCtD
Fenoldopam—Haemorrhage—Fluorouracil—stomach cancer	0.00274	0.00561	CcSEcCtD
Fenoldopam—Oliguria—Doxorubicin—stomach cancer	0.00267	0.00546	CcSEcCtD
Fenoldopam—Flushing—Irinotecan—stomach cancer	0.00266	0.00543	CcSEcCtD
Fenoldopam—Injection site reaction—Epirubicin—stomach cancer	0.00264	0.0054	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Docetaxel—stomach cancer	0.00261	0.00534	CcSEcCtD
Fenoldopam—Blood creatinine increased—Capecitabine—stomach cancer	0.0026	0.00531	CcSEcCtD
Fenoldopam—Creatinine increased—Doxorubicin—stomach cancer	0.00258	0.00528	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Capecitabine—stomach cancer	0.00253	0.00517	CcSEcCtD
Fenoldopam—Hypokalaemia—Capecitabine—stomach cancer	0.00252	0.00516	CcSEcCtD
Fenoldopam—Blood urea increased—Epirubicin—stomach cancer	0.00251	0.00513	CcSEcCtD
Fenoldopam—Injection site reaction—Doxorubicin—stomach cancer	0.00245	0.005	CcSEcCtD
Fenoldopam—Back pain—Irinotecan—stomach cancer	0.00241	0.00493	CcSEcCtD
Fenoldopam—Angina pectoris—Docetaxel—stomach cancer	0.00241	0.00493	CcSEcCtD
Fenoldopam—Muscle spasms—Irinotecan—stomach cancer	0.0024	0.0049	CcSEcCtD
Fenoldopam—Angina pectoris—Capecitabine—stomach cancer	0.00233	0.00477	CcSEcCtD
Fenoldopam—Blood urea increased—Doxorubicin—stomach cancer	0.00232	0.00475	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Docetaxel—stomach cancer	0.00217	0.00444	CcSEcCtD
Fenoldopam—Myocardial infarction—Docetaxel—stomach cancer	0.00216	0.00442	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Capecitabine—stomach cancer	0.0021	0.0043	CcSEcCtD
Fenoldopam—Myocardial infarction—Capecitabine—stomach cancer	0.00209	0.00428	CcSEcCtD
Fenoldopam—Urinary tract infection—Capecitabine—stomach cancer	0.00208	0.00424	CcSEcCtD
Fenoldopam—Chest pain—Fluorouracil—stomach cancer	0.00203	0.00416	CcSEcCtD
Fenoldopam—Haemoglobin—Docetaxel—stomach cancer	0.00199	0.00407	CcSEcCtD
Fenoldopam—Haemorrhage—Docetaxel—stomach cancer	0.00198	0.00405	CcSEcCtD
Fenoldopam—Cardiac failure—Epirubicin—stomach cancer	0.00198	0.00404	CcSEcCtD
Fenoldopam—Hyperhidrosis—Irinotecan—stomach cancer	0.00197	0.00402	CcSEcCtD
Fenoldopam—Bradycardia—Capecitabine—stomach cancer	0.00195	0.00399	CcSEcCtD
Fenoldopam—Haemoglobin—Capecitabine—stomach cancer	0.00193	0.00394	CcSEcCtD
Fenoldopam—Haemorrhage—Capecitabine—stomach cancer	0.00192	0.00392	CcSEcCtD
Fenoldopam—Tachycardia—Fluorouracil—stomach cancer	0.0019	0.00389	CcSEcCtD
Fenoldopam—Hypotension—Irinotecan—stomach cancer	0.0019	0.00389	CcSEcCtD
Fenoldopam—Insomnia—Irinotecan—stomach cancer	0.00184	0.00376	CcSEcCtD
Fenoldopam—Flushing—Docetaxel—stomach cancer	0.00184	0.00376	CcSEcCtD
Fenoldopam—Cardiac failure—Doxorubicin—stomach cancer	0.00183	0.00374	CcSEcCtD
Fenoldopam—Hypotension—Fluorouracil—stomach cancer	0.00182	0.00372	CcSEcCtD
Fenoldopam—Dyspnoea—Irinotecan—stomach cancer	0.00181	0.00371	CcSEcCtD
Fenoldopam—Blood creatinine increased—Epirubicin—stomach cancer	0.00181	0.0037	CcSEcCtD
Fenoldopam—Flushing—Capecitabine—stomach cancer	0.00178	0.00364	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Epirubicin—stomach cancer	0.00176	0.0036	CcSEcCtD
Fenoldopam—Insomnia—Fluorouracil—stomach cancer	0.00176	0.0036	CcSEcCtD
Fenoldopam—Hypokalaemia—Epirubicin—stomach cancer	0.00176	0.00359	CcSEcCtD
Fenoldopam—Constipation—Irinotecan—stomach cancer	0.00174	0.00356	CcSEcCtD
Fenoldopam—Dyspnoea—Fluorouracil—stomach cancer	0.00174	0.00355	CcSEcCtD
Fenoldopam—Blood creatinine increased—Doxorubicin—stomach cancer	0.00167	0.00342	CcSEcCtD
Fenoldopam—Back pain—Docetaxel—stomach cancer	0.00167	0.00341	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Irinotecan—stomach cancer	0.00166	0.0034	CcSEcCtD
Fenoldopam—Muscle spasms—Docetaxel—stomach cancer	0.00166	0.00339	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Doxorubicin—stomach cancer	0.00163	0.00333	CcSEcCtD
Fenoldopam—Hypokalaemia—Doxorubicin—stomach cancer	0.00163	0.00332	CcSEcCtD
Fenoldopam—Angina pectoris—Epirubicin—stomach cancer	0.00163	0.00332	CcSEcCtD
Fenoldopam—Back pain—Capecitabine—stomach cancer	0.00161	0.0033	CcSEcCtD
Fenoldopam—Abdominal pain—Irinotecan—stomach cancer	0.00161	0.00329	CcSEcCtD
Fenoldopam—Body temperature increased—Irinotecan—stomach cancer	0.00161	0.00329	CcSEcCtD
Fenoldopam—Muscle spasms—Capecitabine—stomach cancer	0.0016	0.00328	CcSEcCtD
Fenoldopam—Body temperature increased—Fluorouracil—stomach cancer	0.00154	0.00315	CcSEcCtD
Fenoldopam—Sweating—Methotrexate—stomach cancer	0.00152	0.00312	CcSEcCtD
Fenoldopam—Palpitations—Docetaxel—stomach cancer	0.00152	0.00311	CcSEcCtD
Fenoldopam—Angina pectoris—Doxorubicin—stomach cancer	0.0015	0.00307	CcSEcCtD
Fenoldopam—Palpitations—Capecitabine—stomach cancer	0.00147	0.00301	CcSEcCtD
Fenoldopam—Chest pain—Docetaxel—stomach cancer	0.00147	0.003	CcSEcCtD
Fenoldopam—Urinary tract infection—Epirubicin—stomach cancer	0.00145	0.00296	CcSEcCtD
Fenoldopam—Haemoglobin—Methotrexate—stomach cancer	0.00143	0.00293	CcSEcCtD
Fenoldopam—Haemorrhage—Methotrexate—stomach cancer	0.00143	0.00292	CcSEcCtD
Fenoldopam—Sweating—Epirubicin—stomach cancer	0.00143	0.00292	CcSEcCtD
Fenoldopam—Chest pain—Capecitabine—stomach cancer	0.00142	0.0029	CcSEcCtD
Fenoldopam—Anxiety—Capecitabine—stomach cancer	0.00142	0.00289	CcSEcCtD
Fenoldopam—Diarrhoea—Irinotecan—stomach cancer	0.00139	0.00285	CcSEcCtD
Fenoldopam—Tachycardia—Docetaxel—stomach cancer	0.00137	0.00281	CcSEcCtD
Fenoldopam—Bradycardia—Epirubicin—stomach cancer	0.00136	0.00278	CcSEcCtD
Fenoldopam—Dizziness—Irinotecan—stomach cancer	0.00135	0.00275	CcSEcCtD
Fenoldopam—Haemoglobin—Epirubicin—stomach cancer	0.00134	0.00274	CcSEcCtD
Fenoldopam—Urinary tract infection—Doxorubicin—stomach cancer	0.00134	0.00274	CcSEcCtD
Fenoldopam—Haemorrhage—Epirubicin—stomach cancer	0.00134	0.00273	CcSEcCtD
Fenoldopam—Diarrhoea—Fluorouracil—stomach cancer	0.00133	0.00273	CcSEcCtD
Fenoldopam—Tachycardia—Capecitabine—stomach cancer	0.00133	0.00272	CcSEcCtD
Fenoldopam—Sweating—Doxorubicin—stomach cancer	0.00132	0.0027	CcSEcCtD
Fenoldopam—Hyperhidrosis—Capecitabine—stomach cancer	0.00132	0.00269	CcSEcCtD
Fenoldopam—Hypotension—Docetaxel—stomach cancer	0.00131	0.00269	CcSEcCtD
Fenoldopam—Vomiting—Irinotecan—stomach cancer	0.00129	0.00264	CcSEcCtD
Fenoldopam—Dizziness—Fluorouracil—stomach cancer	0.00129	0.00263	CcSEcCtD
Fenoldopam—Headache—Irinotecan—stomach cancer	0.00127	0.00261	CcSEcCtD
Fenoldopam—Hypotension—Capecitabine—stomach cancer	0.00127	0.0026	CcSEcCtD
Fenoldopam—Insomnia—Docetaxel—stomach cancer	0.00127	0.0026	CcSEcCtD
Fenoldopam—Bradycardia—Doxorubicin—stomach cancer	0.00126	0.00257	CcSEcCtD
Fenoldopam—Dyspnoea—Docetaxel—stomach cancer	0.00125	0.00256	CcSEcCtD
Fenoldopam—Haemoglobin—Doxorubicin—stomach cancer	0.00124	0.00254	CcSEcCtD
Fenoldopam—Flushing—Epirubicin—stomach cancer	0.00124	0.00253	CcSEcCtD
Fenoldopam—Vomiting—Fluorouracil—stomach cancer	0.00124	0.00253	CcSEcCtD
Fenoldopam—Haemorrhage—Doxorubicin—stomach cancer	0.00124	0.00253	CcSEcCtD
Fenoldopam—Insomnia—Capecitabine—stomach cancer	0.00123	0.00252	CcSEcCtD
Fenoldopam—Headache—Fluorouracil—stomach cancer	0.00122	0.0025	CcSEcCtD
Fenoldopam—Dyspnoea—Capecitabine—stomach cancer	0.00121	0.00248	CcSEcCtD
Fenoldopam—Nausea—Irinotecan—stomach cancer	0.00121	0.00247	CcSEcCtD
Fenoldopam—Constipation—Docetaxel—stomach cancer	0.0012	0.00246	CcSEcCtD
Fenoldopam—Back pain—Methotrexate—stomach cancer	0.0012	0.00246	CcSEcCtD
Fenoldopam—Constipation—Capecitabine—stomach cancer	0.00116	0.00238	CcSEcCtD
Fenoldopam—Nausea—Fluorouracil—stomach cancer	0.00116	0.00237	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Docetaxel—stomach cancer	0.00115	0.00235	CcSEcCtD
Fenoldopam—Flushing—Doxorubicin—stomach cancer	0.00115	0.00234	CcSEcCtD
Fenoldopam—Tension—Epirubicin—stomach cancer	0.00114	0.00233	CcSEcCtD
Fenoldopam—Nervousness—Epirubicin—stomach cancer	0.00113	0.00231	CcSEcCtD
Fenoldopam—Back pain—Epirubicin—stomach cancer	0.00112	0.0023	CcSEcCtD
Fenoldopam—Muscle spasms—Epirubicin—stomach cancer	0.00112	0.00228	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Capecitabine—stomach cancer	0.00111	0.00228	CcSEcCtD
Fenoldopam—Abdominal pain—Docetaxel—stomach cancer	0.00111	0.00227	CcSEcCtD
Fenoldopam—Body temperature increased—Docetaxel—stomach cancer	0.00111	0.00227	CcSEcCtD
Fenoldopam—Abdominal pain—Capecitabine—stomach cancer	0.00108	0.0022	CcSEcCtD
Fenoldopam—Body temperature increased—Capecitabine—stomach cancer	0.00108	0.0022	CcSEcCtD
Fenoldopam—Chest pain—Methotrexate—stomach cancer	0.00106	0.00216	CcSEcCtD
Fenoldopam—Tension—Doxorubicin—stomach cancer	0.00106	0.00216	CcSEcCtD
Fenoldopam—Nervousness—Doxorubicin—stomach cancer	0.00104	0.00214	CcSEcCtD
Fenoldopam—Back pain—Doxorubicin—stomach cancer	0.00104	0.00213	CcSEcCtD
Fenoldopam—Muscle spasms—Doxorubicin—stomach cancer	0.00103	0.00211	CcSEcCtD
Fenoldopam—Palpitations—Epirubicin—stomach cancer	0.00103	0.0021	CcSEcCtD
Fenoldopam—Chest pain—Epirubicin—stomach cancer	0.00099	0.00202	CcSEcCtD
Fenoldopam—Anxiety—Epirubicin—stomach cancer	0.000986	0.00202	CcSEcCtD
Fenoldopam—Hyperhidrosis—Methotrexate—stomach cancer	0.00098	0.002	CcSEcCtD
Fenoldopam—Diarrhoea—Docetaxel—stomach cancer	0.000962	0.00197	CcSEcCtD
Fenoldopam—Palpitations—Doxorubicin—stomach cancer	0.000951	0.00194	CcSEcCtD
Fenoldopam—Hypotension—Methotrexate—stomach cancer	0.000947	0.00194	CcSEcCtD
Fenoldopam—Diarrhoea—Capecitabine—stomach cancer	0.000932	0.0019	CcSEcCtD
Fenoldopam—Dizziness—Docetaxel—stomach cancer	0.00093	0.0019	CcSEcCtD
Fenoldopam—Tachycardia—Epirubicin—stomach cancer	0.000926	0.00189	CcSEcCtD
Fenoldopam—Hyperhidrosis—Epirubicin—stomach cancer	0.000917	0.00188	CcSEcCtD
Fenoldopam—Insomnia—Methotrexate—stomach cancer	0.000917	0.00187	CcSEcCtD
Fenoldopam—Chest pain—Doxorubicin—stomach cancer	0.000916	0.00187	CcSEcCtD
Fenoldopam—Anxiety—Doxorubicin—stomach cancer	0.000913	0.00187	CcSEcCtD
Fenoldopam—Dyspnoea—Methotrexate—stomach cancer	0.000904	0.00185	CcSEcCtD
Fenoldopam—Dizziness—Capecitabine—stomach cancer	0.000901	0.00184	CcSEcCtD
Fenoldopam—Vomiting—Docetaxel—stomach cancer	0.000894	0.00183	CcSEcCtD
Fenoldopam—Hypotension—Epirubicin—stomach cancer	0.000887	0.00181	CcSEcCtD
Fenoldopam—Headache—Docetaxel—stomach cancer	0.000881	0.0018	CcSEcCtD
Fenoldopam—Vomiting—Capecitabine—stomach cancer	0.000866	0.00177	CcSEcCtD
Fenoldopam—Insomnia—Epirubicin—stomach cancer	0.000858	0.00175	CcSEcCtD
Fenoldopam—Tachycardia—Doxorubicin—stomach cancer	0.000857	0.00175	CcSEcCtD
Fenoldopam—Headache—Capecitabine—stomach cancer	0.000853	0.00174	CcSEcCtD
Fenoldopam—Hyperhidrosis—Doxorubicin—stomach cancer	0.000849	0.00173	CcSEcCtD
Fenoldopam—Dyspnoea—Epirubicin—stomach cancer	0.000846	0.00173	CcSEcCtD
Fenoldopam—Nausea—Docetaxel—stomach cancer	0.000836	0.00171	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Methotrexate—stomach cancer	0.000829	0.00169	CcSEcCtD
Fenoldopam—Hypotension—Doxorubicin—stomach cancer	0.00082	0.00168	CcSEcCtD
Fenoldopam—Constipation—Epirubicin—stomach cancer	0.000811	0.00166	CcSEcCtD
Fenoldopam—Nausea—Capecitabine—stomach cancer	0.000809	0.00165	CcSEcCtD
Fenoldopam—Abdominal pain—Methotrexate—stomach cancer	0.000801	0.00164	CcSEcCtD
Fenoldopam—Body temperature increased—Methotrexate—stomach cancer	0.000801	0.00164	CcSEcCtD
Fenoldopam—Insomnia—Doxorubicin—stomach cancer	0.000794	0.00162	CcSEcCtD
Fenoldopam—Dyspnoea—Doxorubicin—stomach cancer	0.000783	0.0016	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Epirubicin—stomach cancer	0.000776	0.00159	CcSEcCtD
Fenoldopam—Constipation—Doxorubicin—stomach cancer	0.000751	0.00153	CcSEcCtD
Fenoldopam—Body temperature increased—Epirubicin—stomach cancer	0.00075	0.00153	CcSEcCtD
Fenoldopam—Abdominal pain—Epirubicin—stomach cancer	0.00075	0.00153	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000718	0.00147	CcSEcCtD
Fenoldopam—Abdominal pain—Doxorubicin—stomach cancer	0.000694	0.00142	CcSEcCtD
Fenoldopam—Body temperature increased—Doxorubicin—stomach cancer	0.000694	0.00142	CcSEcCtD
Fenoldopam—Diarrhoea—Methotrexate—stomach cancer	0.000694	0.00142	CcSEcCtD
Fenoldopam—Dizziness—Methotrexate—stomach cancer	0.00067	0.00137	CcSEcCtD
Fenoldopam—Diarrhoea—Epirubicin—stomach cancer	0.000649	0.00133	CcSEcCtD
Fenoldopam—Vomiting—Methotrexate—stomach cancer	0.000645	0.00132	CcSEcCtD
Fenoldopam—Headache—Methotrexate—stomach cancer	0.000635	0.0013	CcSEcCtD
Fenoldopam—Dizziness—Epirubicin—stomach cancer	0.000627	0.00128	CcSEcCtD
Fenoldopam—Vomiting—Epirubicin—stomach cancer	0.000603	0.00123	CcSEcCtD
Fenoldopam—Nausea—Methotrexate—stomach cancer	0.000602	0.00123	CcSEcCtD
Fenoldopam—Diarrhoea—Doxorubicin—stomach cancer	0.000601	0.00123	CcSEcCtD
Fenoldopam—Headache—Epirubicin—stomach cancer	0.000594	0.00122	CcSEcCtD
Fenoldopam—Dizziness—Doxorubicin—stomach cancer	0.000581	0.00119	CcSEcCtD
Fenoldopam—Nausea—Epirubicin—stomach cancer	0.000564	0.00115	CcSEcCtD
Fenoldopam—Vomiting—Doxorubicin—stomach cancer	0.000558	0.00114	CcSEcCtD
Fenoldopam—Headache—Doxorubicin—stomach cancer	0.00055	0.00112	CcSEcCtD
Fenoldopam—Nausea—Doxorubicin—stomach cancer	0.000521	0.00107	CcSEcCtD
Fenoldopam—ADRA1A—Signaling Pathways—APOA1—stomach cancer	3.81e-05	7.47e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—PIK3CA—stomach cancer	3.79e-05	7.41e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PRKCB—stomach cancer	3.78e-05	7.39e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6ST—stomach cancer	3.76e-05	7.36e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—MAPK3—stomach cancer	3.75e-05	7.35e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—PIK3CA—stomach cancer	3.73e-05	7.31e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PPARG—stomach cancer	3.73e-05	7.31e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ERBB2—stomach cancer	3.72e-05	7.28e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—PIK3CA—stomach cancer	3.71e-05	7.27e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SERPINE1—stomach cancer	3.71e-05	7.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6R—stomach cancer	3.7e-05	7.24e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—KRAS—stomach cancer	3.67e-05	7.18e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ERBB2—stomach cancer	3.67e-05	7.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IRS2—stomach cancer	3.66e-05	7.17e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—KRAS—stomach cancer	3.66e-05	7.17e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6R—stomach cancer	3.64e-05	7.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	3.64e-05	7.12e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—MAPK1—stomach cancer	3.63e-05	7.11e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—EGFR—stomach cancer	3.63e-05	7.1e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	3.62e-05	7.09e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—stomach cancer	3.62e-05	7.08e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APC—stomach cancer	3.61e-05	7.08e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—RHOA—stomach cancer	3.58e-05	7e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—MAPK1—stomach cancer	3.57e-05	6.99e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—EGFR—stomach cancer	3.57e-05	6.99e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CAV1—stomach cancer	3.55e-05	6.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOA1—stomach cancer	3.54e-05	6.94e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOS3—stomach cancer	3.54e-05	6.93e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CXCL8—stomach cancer	3.53e-05	6.9e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—HRAS—stomach cancer	3.5e-05	6.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APC—stomach cancer	3.48e-05	6.82e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CXCL8—stomach cancer	3.48e-05	6.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—PIK3CA—stomach cancer	3.47e-05	6.79e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SERPINE1—stomach cancer	3.46e-05	6.78e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—MAPK3—stomach cancer	3.46e-05	6.78e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—HRAS—stomach cancer	3.46e-05	6.76e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CDKN1B—stomach cancer	3.44e-05	6.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—KRAS—stomach cancer	3.43e-05	6.71e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—PIK3CA—stomach cancer	3.41e-05	6.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SERPINE1—stomach cancer	3.41e-05	6.67e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CDKN1B—stomach cancer	3.4e-05	6.65e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	3.38e-05	6.62e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—KRAS—stomach cancer	3.37e-05	6.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—PIK3CA—stomach cancer	3.37e-05	6.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	3.37e-05	6.59e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PIK3CA—stomach cancer	3.37e-05	6.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—stomach cancer	3.36e-05	6.57e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6R—stomach cancer	3.36e-05	6.57e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6—stomach cancer	3.35e-05	6.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—RHOA—stomach cancer	3.34e-05	6.54e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	3.33e-05	6.53e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ERBB2—stomach cancer	3.31e-05	6.48e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6—stomach cancer	3.31e-05	6.47e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOS3—stomach cancer	3.31e-05	6.47e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—MAPK1—stomach cancer	3.29e-05	6.45e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—EGFR—stomach cancer	3.29e-05	6.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RHOA—stomach cancer	3.29e-05	6.44e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCND1—stomach cancer	3.28e-05	6.43e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—JUN—stomach cancer	3.28e-05	6.42e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—stomach cancer	3.26e-05	6.37e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOS3—stomach cancer	3.25e-05	6.37e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCND1—stomach cancer	3.24e-05	6.34e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APC—stomach cancer	3.24e-05	6.33e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6R—stomach cancer	3.23e-05	6.33e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—JUN—stomach cancer	3.23e-05	6.33e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—NOS3—stomach cancer	3.21e-05	6.29e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—stomach cancer	3.19e-05	6.24e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CDKN1A—stomach cancer	3.18e-05	6.22e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	3.17e-05	6.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	3.17e-05	6.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PIK3CA—stomach cancer	3.15e-05	6.17e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	3.15e-05	6.16e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—stomach cancer	3.15e-05	6.16e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SERPINE1—stomach cancer	3.14e-05	6.15e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	3.14e-05	6.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CDKN1A—stomach cancer	3.13e-05	6.14e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	3.12e-05	6.11e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HRAS—stomach cancer	3.11e-05	6.1e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—KRAS—stomach cancer	3.11e-05	6.09e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK8—stomach cancer	3.1e-05	6.07e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	3.1e-05	6.07e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	3.1e-05	6.07e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ERBB2—stomach cancer	3.09e-05	6.05e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	3.07e-05	6e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK8—stomach cancer	3.06e-05	5.99e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	3.04e-05	5.96e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	3.03e-05	5.94e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RHOA—stomach cancer	3.03e-05	5.93e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	3.03e-05	5.93e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6R—stomach cancer	3e-05	5.88e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOS3—stomach cancer	3e-05	5.87e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	3e-05	5.87e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—stomach cancer	2.99e-05	5.85e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—stomach cancer	2.98e-05	5.83e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	2.95e-05	5.77e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	2.95e-05	5.77e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—stomach cancer	2.94e-05	5.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	2.93e-05	5.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCND1—stomach cancer	2.93e-05	5.73e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RHOA—stomach cancer	2.92e-05	5.72e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—JUN—stomach cancer	2.92e-05	5.71e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	2.91e-05	5.7e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOS3—stomach cancer	2.89e-05	5.66e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	2.89e-05	5.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	2.87e-05	5.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	2.86e-05	5.61e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—stomach cancer	2.86e-05	5.6e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	2.86e-05	5.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—stomach cancer	2.84e-05	5.56e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—STAT3—stomach cancer	2.83e-05	5.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	2.83e-05	5.54e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	2.82e-05	5.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	2.82e-05	5.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	2.82e-05	5.51e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	2.81e-05	5.51e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ERBB2—stomach cancer	2.81e-05	5.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—STAT3—stomach cancer	2.8e-05	5.48e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—stomach cancer	2.79e-05	5.46e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	2.78e-05	5.45e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	2.76e-05	5.41e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	2.75e-05	5.39e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—stomach cancer	2.74e-05	5.37e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCND1—stomach cancer	2.73e-05	5.35e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—JUN—stomach cancer	2.73e-05	5.34e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RHOA—stomach cancer	2.71e-05	5.31e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK3—stomach cancer	2.71e-05	5.3e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	2.7e-05	5.29e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCND1—stomach cancer	2.69e-05	5.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOS3—stomach cancer	2.69e-05	5.26e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—JUN—stomach cancer	2.68e-05	5.25e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	2.67e-05	5.23e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCL8—stomach cancer	2.66e-05	5.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—stomach cancer	2.65e-05	5.19e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HRAS—stomach cancer	2.64e-05	5.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	2.64e-05	5.17e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—stomach cancer	2.63e-05	5.16e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—stomach cancer	2.61e-05	5.11e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	2.6e-05	5.09e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDKN1B—stomach cancer	2.6e-05	5.09e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—stomach cancer	2.6e-05	5.09e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	2.58e-05	5.05e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK1—stomach cancer	2.58e-05	5.04e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EGFR—stomach cancer	2.58e-05	5.04e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	2.56e-05	5.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	2.56e-05	5.01e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	2.55e-05	4.99e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	2.55e-05	4.99e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	2.54e-05	4.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EGFR—stomach cancer	2.54e-05	4.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	2.54e-05	4.97e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—stomach cancer	2.53e-05	4.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—STAT3—stomach cancer	2.53e-05	4.94e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	2.51e-05	4.92e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	2.5e-05	4.9e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCND1—stomach cancer	2.48e-05	4.85e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—JUN—stomach cancer	2.47e-05	4.84e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—stomach cancer	2.44e-05	4.77e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KRAS—stomach cancer	2.43e-05	4.76e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	2.41e-05	4.72e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—stomach cancer	2.41e-05	4.71e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KRAS—stomach cancer	2.4e-05	4.7e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDKN1A—stomach cancer	2.4e-05	4.7e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCND1—stomach cancer	2.39e-05	4.68e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—JUN—stomach cancer	2.38e-05	4.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	2.38e-05	4.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	2.38e-05	4.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	2.37e-05	4.63e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STAT3—stomach cancer	2.36e-05	4.62e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—stomach cancer	2.35e-05	4.59e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	2.34e-05	4.59e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK8—stomach cancer	2.34e-05	4.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	2.33e-05	4.55e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STAT3—stomach cancer	2.32e-05	4.54e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—stomach cancer	2.32e-05	4.54e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	2.31e-05	4.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	2.3e-05	4.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EGFR—stomach cancer	2.3e-05	4.49e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—stomach cancer	2.27e-05	4.43e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	2.26e-05	4.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	2.25e-05	4.41e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CA—stomach cancer	2.24e-05	4.38e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CA—stomach cancer	2.23e-05	4.36e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCND1—stomach cancer	2.22e-05	4.34e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	2.22e-05	4.34e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—JUN—stomach cancer	2.21e-05	4.34e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	2.21e-05	4.32e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—stomach cancer	2.19e-05	4.29e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KRAS—stomach cancer	2.17e-05	4.24e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—stomach cancer	2.16e-05	4.23e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—stomach cancer	2.16e-05	4.23e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—stomach cancer	2.16e-05	4.22e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—stomach cancer	2.15e-05	4.22e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	2.15e-05	4.2e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	2.14e-05	4.2e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EGFR—stomach cancer	2.14e-05	4.2e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STAT3—stomach cancer	2.14e-05	4.19e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—stomach cancer	2.13e-05	4.18e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	2.11e-05	4.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EGFR—stomach cancer	2.11e-05	4.13e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	2.1e-05	4.1e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	2.08e-05	4.08e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HRAS—stomach cancer	2.07e-05	4.05e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STAT3—stomach cancer	2.06e-05	4.04e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.04e-05	4e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HRAS—stomach cancer	2.04e-05	4e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KRAS—stomach cancer	2.03e-05	3.96e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KRAS—stomach cancer	1.99e-05	3.9e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	1.99e-05	3.9e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—stomach cancer	1.99e-05	3.89e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—stomach cancer	1.98e-05	3.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	1.97e-05	3.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—stomach cancer	1.95e-05	3.82e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK1—stomach cancer	1.95e-05	3.81e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGFR—stomach cancer	1.95e-05	3.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	1.93e-05	3.79e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—stomach cancer	1.93e-05	3.77e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—stomach cancer	1.92e-05	3.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STAT3—stomach cancer	1.92e-05	3.75e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	1.87e-05	3.67e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGFR—stomach cancer	1.87e-05	3.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	1.86e-05	3.64e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HRAS—stomach cancer	1.84e-05	3.61e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KRAS—stomach cancer	1.84e-05	3.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	1.83e-05	3.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	1.83e-05	3.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CA—stomach cancer	1.81e-05	3.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—stomach cancer	1.8e-05	3.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—stomach cancer	1.78e-05	3.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—stomach cancer	1.77e-05	3.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KRAS—stomach cancer	1.77e-05	3.47e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—stomach cancer	1.76e-05	3.45e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.74e-05	3.41e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.74e-05	3.41e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HRAS—stomach cancer	1.72e-05	3.37e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HRAS—stomach cancer	1.69e-05	3.32e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CA—stomach cancer	1.69e-05	3.3e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—stomach cancer	1.65e-05	3.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.65e-05	3.22e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—stomach cancer	1.63e-05	3.2e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	1.63e-05	3.18e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—stomach cancer	1.62e-05	3.17e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—stomach cancer	1.57e-05	3.08e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HRAS—stomach cancer	1.56e-05	3.06e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.51e-05	2.96e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HRAS—stomach cancer	1.5e-05	2.95e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—stomach cancer	1.49e-05	2.93e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.46e-05	2.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—stomach cancer	1.44e-05	2.82e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.4e-05	2.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.34e-05	2.62e-05	CbGpPWpGaD
